CTOs on the Move

InflaRx

www.inflarx.com

 
InflaRx (Nasdaq:IFRX) is a clinical-stage biopharmaceutical company focused on applying its proprietary anti-C5a technology to discover and develop first-in-class, potent and specific inhibitors of C5a. Complement C5a is a powerful inflammatory mediator involved in the progression of a wide variety of autoimmune and other inflammatory diseases. InflaRx was founded in 2007 and the group has offices and subsidiaries in Jena and Munich, Germany as well as Ann Arbor, Michigan. InflaRx is listed on the Nasdaq Global Select Market in the United States under the trading symbol “IFRX”.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Similar Companies

Castle Hill Technologies

Castle Hill Technologies is a Attleboro Falls, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Symphogen

Symphogen, Inc. is a Princeton, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Lucentis

Lucentis is a South San Francisco, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Irix Pharmaceuticals

Irix Pharmaceuticals is a Florence, SC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Novartis

5764914 Novartis International AG is a Swiss multinational pharmaceutical company based in Basel, Switzerland.